A long term feed supplementation based on phosphate binders in Feline Chronic Kidney Disease
Chronic kidney disease (CKD) is a very common disorder in elderly cats. A proper renal diet represents the most efficient therapeutic intervention to improve survival and life quality in feline patients with 3 and 4 International Renal Interest Society (IRIS) stages. Twenty cats were selected in this study. Ten were administered the dietary supplementation for 360 days and the other ten, whose owners did not give consent for any supplemental therapies apart from the renal diet, were selected from a clinical database and used as control group. The present study is a long term study (360 days) aiming to evaluate the efficacy and palatability of a dietary supplementation containing calcium carbonate, calcium-lactate gluconate, chitosan and sodium bicarbonate in cats diagnosed with 3 and 4 IRIS stages of CKD. The owners were asked to fill in questionnaires to get information on the cat’s appetite, the palatability of the given supplement, the presence of vomit and/or diarrhoea, general health and vitality. Hematochemical, biochemical and urinary analyses were performed on day 0, 30, 60, 90, 120, 150,180 and 360. GraphPad Prism® software was used to perform statistical analysis. Our study shows that the given dietary supplement reduced serum phosphorus and increased serum bicarbonate values in cats with CKD. In turn, this supplement could be used as a support therapy in cats with advanced CKD improving their clinical conditions without any adverse reaction. Finally, it is important to underline that all the animals completed the study and the owners reported a good palatability of the feed supplement.
KeywordsCat Chronic kidney disease Feed supplement Phosphate binder
Compliance with Ethical Standards
All procedures, treatments and animal care were in compliance with the guidelines of the Italian Minister of Health for the care and use of animals (D.L. 4 March 2014 n. 26 and D.L. 27 January 1992 n.116) and UE (Directive 86/609/CEE).
Conflict of interest
Two of the authors are employees of Candioli Farmaceutici S.p.A.
- Caney SM (2016) An online survey of dietary and phosphate binder practices of owners of cats with chronic kidney disease. J Feline Med Surg 17.pii:1098612X16672999. [Epub ahead of print]Google Scholar
- Fédération européenne de l’industrie des aliments pour animaux familiers (FEDIAF) (2014) Nutritional guidelines for complete and complementary pet food for cats and dogs. Disponível em: http://www.fediaf.org/self-regulation/nutrition/. Acessado em 12/2015
- Freeman LM, Abood SK, Fascetti AJ, Fleeman LM, Michel KE, Laflamme DP, Bauer C, Kemp BL, Van Doren JR, Willoughby KN (2006) Disease prevalence among dogs and cats in the United States and Australia and proportions of dogs and cats that receive therapeutic diets or dietary supplements. J Am Vet Med Assoc 229:531–534CrossRefPubMedGoogle Scholar
- International Renal Interest Society (IRIS) (2013) Elanco animal health. CKD staging in cats (2013). Disponível em: http://iris-kidney.com/guidelines/staging.aspx. Acessado em 12/2015
- Pettifer G (2002) Fluids, electrolytes, and acid-base therapy. In: Slatter DH (ed) Textbook of small animal surgery, 3rd edn., v. 1, pp 17–43Google Scholar
- Thatcher CD, Hand MS, Remillard RL (2010) Small animal clinical nutrition: an iterative process. In: Hand M, Thatcher C, Remillard R, Roudebush P, Novotny BJ (eds). Small Animal Clinical Nutrition, 5th edn., Mark Morris Institute, pp 3–21Google Scholar
- Vergnano D, Valle E, Bruni N, Bigliati M, Cocca T (2016) Effectiveness of a Feed Supplement in Advanced Stages of Feline Chronic Kidney Disease. Acta Sci Vet 44:1375Google Scholar